Clinical Trials Directory

Trials / Completed

CompletedNCT01773811

Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
University of Mississippi, Oxford · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current study proposes to directly measure how processing after participating in written disclosure about a traumatic life event affects physical and psychological outcomes.

Detailed description

Previous research has established the potential for narrative writing about traumatic events to result in positive benefits for physical and psychological health. Research has also provided evidence that written disclosure may reduce post-traumatic stress disorder (PTSD) symptoms. Several mechanisms of action have been proposed to explain why written disclosure produces positive benefits, but all have focused on processes occurring during the writing session. It has been suggested, however, that additional processing may occur after the writing exercises are over, yet no research has studied the influence of this processing on outcomes. The current study proposes to directly measure how processing after participating in written disclosure affects physical and psychological outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNarrative Writing: Trauma-AssignedIndividuals will be writing about their most traumatic life event for 3 consecutive days for 20 minutes each. Those in the assigned group will be given instructions and weekly reminders to continue to think about their most traumatic event.
BEHAVIORALNarrative Writing: Trauma-SpontaneousIndividuals will be writing about their most traumatic life event for 3 consecutive days for 20 minutes each. Those in the spontaneous group will be given no further instructions.

Timeline

Start date
2012-02-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2013-01-23
Last updated
2014-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01773811. Inclusion in this directory is not an endorsement.